BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15826874)

  • 1. Correlation of susceptibility to 6-aminonicotinamide and hydrocortisone-induced cleft palate.
    Erickson RP; Karolyi IJ; Diehl SR
    Life Sci; 2005 Mar; 76(18):2071-8. PubMed ID: 15826874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confirmation of the role of N-acetyltransferase 2 in teratogen-induced cleft palate using transgenics and knockouts.
    Erickson RP; Cao W; Acuña DK; Strnatka DW; Hunter RJ; Chau BT; Wakefield LV; Sim E; McQueen CA
    Mol Reprod Dev; 2008 Jun; 75(6):1071-6. PubMed ID: 18161794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A region of the mouse genome homologous to human chromosome 1q21 affects facial clefting.
    Karolyi J; Erickson RP
    J Craniofac Genet Dev Biol; 1993; 13(1):1-5. PubMed ID: 8478414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genes, environment, and orofacial clefting: N-acetyltransferase and folic acid.
    Erickson RP
    J Craniofac Surg; 2010 Sep; 21(5):1384-7. PubMed ID: 20818253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of teratogens on maternal corticosterone levels and cleft incidence in A/J mice.
    Sullivan-Jones P; Hansen DK; Sheehan DM; Holson RR
    J Craniofac Genet Dev Biol; 1992; 12(4):183-9. PubMed ID: 1494023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome scan for teratogen-induced clefting susceptibility loci in the mouse: evidence of both allelic and locus heterogeneity distinguishing cleft lip and cleft palate.
    Diehl SR; Erickson RP
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5231-6. PubMed ID: 9144220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-Aminonicotinamide-induced cleft palate in the mouse: the nature of the difference between the A/J and C57Bl/6J strains in frequency of response and its genetic basis.
    Biddle FG
    Teratology; 1977 Dec; 16(3):301-12. PubMed ID: 145663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of susceptibility to 6-aminonicotinamide-induced cleft palate in the mouse: studies in congenic and recombinant inbred strains.
    Karolyi J; Erickson RP; Liu S
    Teratology; 1988 Mar; 37(3):283-7. PubMed ID: 2966993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major gene determination of liability to spontaneous cleft lip in the mouse.
    Biddle FG; Fraser FC
    J Craniofac Genet Dev Biol Suppl; 1986; 2():67-88. PubMed ID: 3491126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of maternal urethane administration on the manifestation of cleft lip and palate in CL/Fr mice.
    Nakane K; Kameyama Y
    J Craniofac Genet Dev Biol Suppl; 1986; 2():109-12. PubMed ID: 3491105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse palatal width growth rates as an "at risk" factor in the development of cleft palate induced by hypervitaminosis A.
    Vergato LA; Doerfler RJ; Mooney MP; Siegel MI
    J Craniofac Genet Dev Biol; 1997; 17(4):204-10. PubMed ID: 9493079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic independence of the embryonic reactivity difference to cortisone- and 6-aminonicotinamide-induced cleft palate in the mouse.
    Biddle FG; Fraser FC
    Teratology; 1979 Apr; 19(2):207-11. PubMed ID: 157557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of clefting in the mouse.
    Juriloff DM
    Prog Clin Biol Res; 1980; 46():39-71. PubMed ID: 7022461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons of the effects of TCDD and hydrocortisone on growth factor expression provide insight into their interaction in the embryonic mouse palate.
    Abbott BD; Harris MW; Birnbaum LS
    Teratology; 1992 Jan; 45(1):35-53. PubMed ID: 1731395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diazepam-induced cleft palate in the mouse and lack of correlation with the H-2 locus.
    Tocco DR; Renskers K; Zimmerman EF
    Teratology; 1987 Jun; 35(3):439-45. PubMed ID: 3629520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allophenic mice in cleft-palate investigations.
    Sulik KM; Atnip RL
    J Embryol Exp Morphol; 1978 Oct; 47():169-77. PubMed ID: 722229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the Ay gene on susceptibility to hydrocortisone fetotoxicity and teratogenicity in mice.
    Teramoto S; Hatakenaka N; Shirasu Y
    Teratology; 1991 Jul; 44(1):101-6. PubMed ID: 1957256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison study of effects of Echinacea extract and levamisole on phenytoin-induced cleft palate in mice.
    Khaksary Mahabady M; Ranjbar R; Arzi A; Papahn AA; Najafzadeh H
    Regul Toxicol Pharmacol; 2006 Dec; 46(3):163-6. PubMed ID: 16889880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrocortisone-induced embryotoxicity and embryonic drug disposition in H-2 congenic mice.
    Roberts LG; Hendrickx AG
    J Craniofac Genet Dev Biol; 1987; 7(4):341-56. PubMed ID: 3429612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with folic acid and methionine in the prevention of retinoic acid-induced cleft palate in mice.
    Reynolds PR; Schaalje GB; Seegmiller RE
    Birth Defects Res A Clin Mol Teratol; 2003 Mar; 67(3):168-73. PubMed ID: 12797458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.